Welcome to our dedicated page for The Cigna Group news (Ticker: CI), a resource for investors and traders seeking the latest updates and insights on The Cigna Group stock.
The Cigna Group (NYSE: CI) is a global health services company dedicated to improving health outcomes and providing comprehensive healthcare solutions. The company operates primarily through two platforms: Evernorth Health Services and Cigna Healthcare. Cigna offers a diverse portfolio of pharmacy, medical, behavioral, dental, and supplemental products and services.
Pharmacy Benefit Management (PBM) and Health Insurance: Cigna's PBM services experienced significant growth following its 2018 merger with Express Scripts. The company's PBM and specialty pharmacy services are primarily sold to health insurance plans and employers, with notable contracts including the Department of Defense and insurer Centene. Cigna serves 18 million U.S. medical members as of December 2023, focusing on self-funded employer arrangements.
Recent Achievements: In 2024, Cigna repurchased $3.2 billion of common stock through accelerated stock repurchase agreements, reflecting strong business growth and commitment to shareholder value. The company is also addressing chronic conditions by introducing innovative solutions like EncircleRx, which offers financial guarantees for managing the cost of GLP-1s.
Partnerships and Community Engagement: Cigna partners with various organizations to enhance community health. This includes sponsoring the NFL's Vincent Country Safe Zone Activity Day, providing essential health screenings and eye exams for students, and participating in behavioral health initiatives through Evernorth Behavioral Care Group.
Financial Performance: Cigna reported strong first-quarter 2024 results, with adjusted income from operations of $1.9 billion, reflecting growth across its Evernorth and Cigna Healthcare businesses. The company also announced pricing terms for tender offers to manage its senior notes, aiming for significant savings for both patients and health plans through biosimilar initiatives.
Future Outlook: As of 2024, Cigna aims to achieve an adjusted EPS growth target of 10%-14% and has reaffirmed its 2024 adjusted EPS guidance of at least $28.25. The company continues to innovate and expand its healthcare offerings, focusing on affordability, access, and improved clinical outcomes.
Cigna Corporation (NYSE: CI) reported strong financial results for 2020, with total revenues of $160.4 billion and shareholders' net income of $8.5 billion ($22.96 per share). Adjusted revenues are projected to reach at least $165 billion for 2021. The company repurchased 21.9 million shares for $4.1 billion in 2020, achieving a debt-to-capitalization ratio of 39.5%. Despite the challenges of the COVID-19 pandemic, Cigna's health services portfolio, boosted by the launch of Evernorth, is positioned for long-term growth.
Cigna's International Markets business released its fourth COVID-19 Global Impact Study, surveying over 23,000 individuals across 11 global markets from January to October 2020. The study highlights heightened stress levels due to uncertainty about the future, with nearly half of respondents citing it as their greatest concern. While overall well-being declined globally, the U.S. saw a 2.6 point improvement. Notably, 59% of respondents are likely to continue using virtual health services post-pandemic, indicating a significant shift in health management preferences.
Cigna Corporation (NYSE:CI) will announce its fourth quarter 2020 financial results on February 4, 2021, at 6:30 a.m. ET. A conference call will follow at 8:30 a.m. ET for management to review results. Call-in numbers are (800) 857-1657 for domestic and (773) 799-3811 for international participants, with a passcode of 242021. A replay will be available until February 18, 2021. Financial documents will be accessible at www.cigna.com under Investor Relations after the earnings release.
Cigna Corporation (NYSE:CI) has appointed George Kurian to its Board of Directors, effective March 1, 2021. Kurian, currently the CEO of NetApp, brings extensive experience in product development and business leadership, previously holding roles at Cisco, Akamai, McKinsey, and Oracle. Cigna's Chairman, Isaiah Harris Jr., emphasized Kurian's expertise as crucial for addressing significant healthcare challenges. President and CEO David Cordani noted that Kurian's background in high-technology global businesses will enhance Cigna's growth and transformation initiatives in healthcare.
Cigna's latest Value of Integration study reveals that integrating medical, pharmacy, and behavioral benefits enhances health engagement and lowers overall costs. Covering over 2.2 million claims, the findings show Cigna clients save an average of $227 annually per customer, with those needing health improvements saving up to $4,741. Notably, expenses drop by over $6,700 for oncology patients and $2,700 for diabetes patients. Improved health engagement was observed, with customers experiencing 21% higher engagement in mental health resources.
Cigna Corporation (NYSE: CI) has announced the initiation of a quarterly dividend of $1.00 per share, with the first payment scheduled for March 25, 2021. This dividend will benefit shareholders on record as of March 10, 2021. CEO David Cordani highlighted this move as a demonstration of Cigna's confidence in its growth potential. Alongside the dividend, the company plans to repurchase at least $2 billion in shares during the first quarter, part of a broader strategy to maximize shareholder value.
Cigna Corporation has integrated Iora Health into its expanding Medicare Advantage (MA) network, effective immediately. This partnership allows Cigna MA customers nationwide to access Iora's patient-centered primary care practices. With locations in major cities like Denver and Houston, Iora specializes in providing convenient and comprehensive care for older adults. The collaboration emphasizes value-based care and preventive health, enhancing patient satisfaction and outcomes. Cigna has recently added over 25,000 physicians to its network, reinforcing its commitment to improving healthcare access and quality.
Cigna Corporation (NYSE:CI) is set to present at the 39th Annual J.P. Morgan Healthcare Conference on Jan. 12, 2021, at approximately 3:40 p.m. ET via a virtual webcast. Interested listeners are advised to join 15 minutes early for necessary software installation. Cigna emphasizes its commitment to enhancing health and well-being through integrated health services, reaching 190 million customer relationships globally. For more details, visit www.cigna.com.
On December 16, 2020, Cigna's International Markets business released the fourth edition of its COVID-19 Global Impact Study, revealing rising concerns about the pandemic's long-term effects. Key findings include that 48% of respondents are stressed by future uncertainty and 45% lack a financial safety net. Well-being scores dropped in several countries, with the U.S. showing an improvement of 2.6 points. The study highlights a shift towards virtual health services, with 59% of respondents likely to use them post-pandemic, suggesting significant changes in health management.
The Cigna Foundation has announced the opening of its Healthier Kids For Our Future® grant program, part of a $25 million initiative aimed at enhancing children's health. In 2021, $5 million in grants will be awarded to schools and nonprofits addressing food insecurity and mental health issues among children, particularly related to loneliness, anxiety, and depression. Since its launch in 2019, the program has allocated over $8 million in grants. Applications open on January 25 and close on February 26, with awards announced in spring 2021.
FAQ
What is the current stock price of The Cigna Group (CI)?
What is the market cap of The Cigna Group (CI)?
What services does The Cigna Group offer?
What is Cigna's primary business focus?
What are some recent achievements of The Cigna Group?
Who are Cigna's key partners?
What are Cigna's future plans?
How does Cigna support community health?
What is Cigna's role in pharmacy benefit management?
What financial initiatives has Cigna undertaken recently?
What are some of Cigna's innovative healthcare solutions?